Massivemarkets

HALO

Halozyme Therapeutics, Inc.

Nasdaq · usd

$127.12+1.49 (+1.19%)
As of 2:27:30 PM EDT on Oct 26, 2026 · 15-minute delayed

Halozyme Therapeutics, Inc. (HALO) trades at $127.12 (+1.19%) as of 2:27:30 PM EDT on Oct 26, 2026, +11.69% over the past month. Market cap is $14.26B, with 4.5 days to cover in short interest.

Stock performance

How Halozyme Therapeutics, Inc. (HALO) stock has performed from one day to one year, with its 52-week range.

+1.27%
+$1.59 over 1D
$125.75$126.33$126.91$127.497:00 AM10:35 AM11:50 AM1:10 PM2:25 PM$127.22
1D
+1.26%
1W
+3.85%
1M
+11.69%
YTD
+89.03%
1Y
+93.19%
52-wk range
$61.23 – $127.77

Key statistics

Today's trading snapshot for HALO: day range, open, previous close, volume and market cap.

Day range
$126.03 – $127.77
Open
$126.03
Prev close
$125.63
Volume
530.98K
Market cap
$14.26B
Shares out
113.5M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Halozyme Therapeutics, Inc.: P/E, P/S, P/B, ROE and more.

P/E
34.48
P/S
8.57
P/B
99.33
P/FCF
17.69
ROE
288.1%
ROA
16.1%
Debt/Equity
14.95
Div yield
0.00%

As of Oct 23, 2026

8-K filings

Material corporate events Halozyme Therapeutics, Inc. has disclosed to the SEC on Form 8-K.

  • Director appointmentSep 30, 2026

    On September 28, 2026, James Daly was elected to the Board of Directors of Halozyme Therapeutics, Inc. Mr. Daly was elected to the class of directors with terms ending at the Company's annual meeting of stockholders in 2029 and was not initially assigned to any Board committee.

  • Private placementSep 22, 2026

    The Company offered and sold the Convertible Notes in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933... The Initial Purchasers offered and sold the Convertible Notes to "qualified institutional buyers" pursuant to the exemption from registration provided by Rule 144A under the Securities Act.

  • Private placementSep 18, 2026

    The Convertible Notes are being offered and sold only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended.

  • Director appointmentAug 18, 2026

    On August 14, 2026, Dannielle Appelhans was elected to the Board of Directors of Halozyme Therapeutics, Inc. (the "Company"). Ms. Appelhans was elected to the class of directors with terms ending at the Company's annual meeting of stockholders in 2028 and was not initially assigned to any Board committee.

  • Executive officer departureJul 2, 2026

    On June 30, 2026, Halozyme Therapeutics, Inc. (the "Company") announced an update to its senior management structure. The company also announced the departure of Cortney Caudill as the Company's Senior Vice President, Chief Operating Officer.

HALO short interest

How heavily HALO is shorted: shares short, days to cover and average daily volume.

Days to cover
4.5
Short interest
15.3M
Avg volume
3.37M

As of · reported to FINRA twice monthly.

HALO news

The latest news and headlines about Halozyme Therapeutics, Inc. (HALO).

Frequently asked questions

What is the Halozyme Therapeutics, Inc. (HALO) stock price today?

Halozyme Therapeutics, Inc. (HALO) is trading at $127.12 (+1.19% on the day) as of 2:27:30 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Halozyme Therapeutics, Inc.?

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors.

What is the short interest in HALO?

As of Sep 30, 2026, HALO has 15.3M shares short and 4.5 days to cover.

What exchange is HALO listed on?

Halozyme Therapeutics, Inc. (HALO) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.

Build with AI

Build an analysis of HALO with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a HALO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.